Company Quick10K Filing
Zeta Acquisition I
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-05-14
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-28
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-14
10-K 2017-12-31 Filed 2018-03-28
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-28
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-13
10-Q 2015-03-31 Filed 2015-05-13
10-K 2014-12-31 Filed 2015-02-27
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-03-28
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-13
10-Q 2010-03-31 Filed 2010-05-17
10-K 2009-12-31 Filed 2010-03-31

Zeta Acquisition I Financials

ZETAI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Equity

Income Statement ($ Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($ Quarterly)

Ops, Inv, Fin

Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Rebel Group (REBL) 0% 0.0 -1,380% 703,462,000 4,932,953,000 139,834,000 0 -9,707,897,000 -9,659,520,000 -395,458,000
Generex Biotechnology (GNBT) 21% 0.0 -49% 52,240,249,000 43,296,964,000 1,764,009,000 374,238,000 -25,717,337,000 -18,297,230,000 -540,256,000
Poverty Dignified (POVD) 0.0 -4,053% 49,338,000 3,079,595,000 0 0 -1,999,816,000 -1,786,224,000 -40,929,000
Zhong Ya (WLUC) 0.0 0 62,889,000 0 0 -561,596,000 -561,596,000 -2,000
Weyland Tech (WEYL) 18% 2.2 -24% 11,699,111,000 2,217,605,000 24,630,065,000 4,371,806,000 -2,778,623,000 -2,702,174,000 -5,820,631,000
Longbau (LNGB) 4% -1.0 2% 10,659,548,000 10,135,830,000 4,882,008,000 209,757,000 164,602,000 221,914,000 -232,744,000
Scandium International Mining (SCY) 0.1 -171% 956,938,000 303,212,000 0 0 -1,636,126,000 -1,634,396,000 -219,146,000
Aprea Therapeutics (APRE) 8.4 -11% 57,336,058,000 9,942,725,000 0 0 -6,249,419,000 -6,249,419,000 -52,334,104,000
IntelliSense Solutions (INLL) 0.0 -7,286% 2,442,000 272,894,000 0 0 -177,936,000 -163,709,000 -2,444,000
Metropolitan Life Insurance (MLIC) 0% -1.8 1% 437,745,000,000,000 403,121,000,000,000 37,348,000,000,000 0 4,559,000,000,000 4,960,000,000,000 -8,986,000,001,000
Zeta Acquisition I (ZETAI) 0.2 -649% 4,412,000 323,686,000 0 0 -28,634,000 -17,937,000 -4,414,000
Ando Holdings (ANDO) 1.1 -74% 73,214,000 159,843,000 0 0 -54,299,000 -53,972,000 -60,816,000
Po Yuen Cultural (POYE) 0.0 -1,973% 1,000,000 68,122,000 0 0 -19,731,000 -19,731,000 -2,000
Advanced Biomedical Technologies (ABMT) 0.0 -321% 218,459,000 6,588,633,000 0 0 -701,078,000 -701,078,000 -10,879,000
Kyto Technology & Life Science (KBPH) 0% 0.8 -12% 2,577,822,000 65,986,000 14,700,000 0 -314,665,000 -314,640,000 -238,429,000
Federal Home Loan Bank of Topeka (FHLBT) 29.6 0% 57,131,130,000,000 54,472,808,000,000 0 0 132,964,000,000 1,095,234,000,000 32,380,960,999,000
CNL Healthcare Properties II (CHPII) 67% -4.4 68,889,100% 8,276,504,000 5,549,239,000 -688,891,000 1,137,086,000 -4,981,415,000
Original Source Music (OSMU) 0.0 743,400% 35,313,000 0 0 -7,434,000 -7,434,000 -2,000
Graham Alternative Investment Fund I (GAIF) -0.0 0% 29,076,020,000 1,126,459,000 0 0 0 4,713,000 -2,000
JiaLiJia Group (RZZN) 0.0 -1,721% 4,000,000 139,328,000 0 0 -68,826,000 -68,826,000 -2,000

Balance Sheet ($)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash6,761,0003,661,0001,727,00021,225,0006,916,0003,022,0002,237,000337,00016,151,0008,026,0004,014,0003,614,0002,299,00015,599,0002,994,00022,594,0009,402,0001,258,0007,427,0001,778,00021,328,0008,885,0005,060,0001,260,0008,145,0003,252,000485,00020,185,00010,235,0004,724,000899,00022,049,0009,679,0004,412,000
Accounts Receivable
Inventory
PP&E
Assets16,151,00012,401,0004,239,0002,299,00015,599,0008,885,0005,060,0001,260,0008,145,0003,252,000485,00020,185,00010,235,0004,724,000899,00022,049,0009,679,0004,412,000
Accounts Payable2,200,0002,497,0002,952,0003,817,000175,000634,0001,850,0006,280,000175,000650,000350,000713,0008,155,00010,682,0002,402,00011,664,0003,575,0004,078,0005,600,0009,613,00011,765,0003,663,0003,750,0008,113,0002,943,0002,404,0001,500,0007,825,0001,700,0001,700,00003,295,0002,500,0002,500,000
Long-Term Debt
Liabilities126,837,000129,226,000136,580,000141,592,000161,320,000218,899,000225,795,000228,510,000244,411,000246,783,000255,090,000283,268,000280,484,000283,861,000291,538,000320,986,000319,918,000323,686,000
Stockholders' Equity-55,463,000-61,729,000-70,638,000-75,986,000-82,300,000-88,313,000-97,975,000-103,937,000-110,686,000-116,825,000-126,576,000-132,341,000-139,293,000-145,721,000-157,374,000-163,189,000-170,461,000-177,282,000-189,483,000-195,689,000-203,372,000-210,014,000-220,735,000-227,250,000-236,266,000-243,531,000-254,605,000-263,083,000-270,249,000-279,137,000-290,639,000-298,937,000-310,239,000-319,274,000
Income Statement ($)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A5,826,0005,359,0008,002,0004,217,0005,042,0004,728,0008,376,0004,705,0005,456,0004,475,0008,087,0004,138,0005,307,0004,765,0009,763,0003,962,0005,103,0004,648,00010,053,0003,962,0005,103,0004,340,0008,112,0003,963,0006,246,0004,354,0008,162,0005,412,0004,970,0005,599,0004,895,0007,675,0005,367,000
Tax
Net Income-6,724,000-6,266,000-8,909,000-5,348,000-6,314,000-6,013,000-9,662,000-5,962,000-6,749,000-6,139,000-9,751,000-5,765,000-6,952,000-6,428,000-11,653,000-5,815,000-7,272,000-6,821,000-12,201,000-6,206,000-7,683,000-6,642,000-10,721,000-6,515,000-9,016,000-7,265,000-11,074,000-8,478,000-7,166,000-8,888,000-8,298,000-11,302,000-9,034,000
Cash Flow ($)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-3,100,000-1,934,000-5,502,000-14,309,000-3,894,000-785,000-1,900,000-9,186,000-8,125,000-4,012,000-400,000-1,315,000-1,700,000-12,605,000-400,000-13,192,000-4,144,000-2,831,000-5,649,000-2,950,000-12,443,000-3,825,000-3,800,000-13,115,000-5,300,000-9,950,000-5,511,000-3,850,000-12,370,000-5,267,000
Cash Investing
Cash Financing0025,000,000000025,000,000000015,000,000020,000,0000-4,000,0009,000,000022,500,0000025,000,0000025,000,00000